Source: RSC Medicinal Chemistry. Unidade: IFSC
Subjects: DOENÇA DE ALZHEIMER, COMPOSTOS HETEROCÍCLICOS, FARMACOCINÉTICA
ABNT
MACHADO, Valkiria et al. Pyrazolines as potential anti-Alzheimer's agents: DFT, molecular docking, enzyme inhibition and pharmacokinetic studies. RSC Medicinal Chemistry, v. 13, n. 12, p. 1644-1656 + supplementary information, 2022Tradução . . Disponível em: https://doi.org/10.1039/D2MD00262K. Acesso em: 17 ago. 2024.APA
Machado, V., Cenci, A. R., Teixeira, K. F., Sens, L., Tizziani, T., Nunes, R. J., et al. (2022). Pyrazolines as potential anti-Alzheimer's agents: DFT, molecular docking, enzyme inhibition and pharmacokinetic studies. RSC Medicinal Chemistry, 13( 12), 1644-1656 + supplementary information. doi:10.1039/D2MD00262KNLM
Machado V, Cenci AR, Teixeira KF, Sens L, Tizziani T, Nunes RJ, Ferreira LLG, Yunes RA, Sandjo LP, Andricopulo AD, Oliveira AS. Pyrazolines as potential anti-Alzheimer's agents: DFT, molecular docking, enzyme inhibition and pharmacokinetic studies [Internet]. RSC Medicinal Chemistry. 2022 ; 13( 12): 1644-1656 + supplementary information.[citado 2024 ago. 17 ] Available from: https://doi.org/10.1039/D2MD00262KVancouver
Machado V, Cenci AR, Teixeira KF, Sens L, Tizziani T, Nunes RJ, Ferreira LLG, Yunes RA, Sandjo LP, Andricopulo AD, Oliveira AS. Pyrazolines as potential anti-Alzheimer's agents: DFT, molecular docking, enzyme inhibition and pharmacokinetic studies [Internet]. RSC Medicinal Chemistry. 2022 ; 13( 12): 1644-1656 + supplementary information.[citado 2024 ago. 17 ] Available from: https://doi.org/10.1039/D2MD00262K